AMERICAN SHARED HOSPITAL SERVICES Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $121.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-31
- AMERICAN SHARED HOSPITAL SERVICES valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $121.00K, a 80.70% decline from fiscal 2024.
- AMERICAN SHARED HOSPITAL SERVICES valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $627.00K, a 3588.24% increase from fiscal 2023.
- AMERICAN SHARED HOSPITAL SERVICES valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $17.00K.
- AMERICAN SHARED HOSPITAL SERVICES valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $121.00K 10-K · filed 2026-03-31 | |
| 2024-12-31 | $627.00K 10-K · filed 2026-03-31 | |
| 2023-12-31 | $17.00K 10-K · filed 2025-04-04 | |
| 2022-12-31 | $0.00 10-K · filed 2024-04-01 | |
| 2021-12-31 | $19.00K 10-K · filed 2023-03-31 | $465.00K 10-K · filed 2022-03-30 |
| 2020-12-31 | $243.00K 10-K · filed 2022-03-30 | -$243.00K 10-K · filed 2021-04-06 |
| 2019-12-31 | -$175.00K 10-K · filed 2021-04-06 | |
| 2018-12-31 | $34.00K 10-K · filed 2020-04-03 | |
| 2017-12-31 | -$303.00K 10-K · filed 2020-04-03 | $303.00K 10-K · filed 2018-03-28 |
| 2016-12-31 | $25.00K 10-K · filed 2019-03-29 | |
| 2015-12-31 | $792.00K 10-K · filed 2018-03-28 | |
| 2014-12-31 | $416.00K 10-K · filed 2017-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |